🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This 4 arm study assessed the efficacy and safety of oral capecitabine (Xel...
Status
Completed
Location
Multiple Locations
Start Date
2003-07
Trial ID
NCT00069095
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Completed
Location
Bank of Cyprus Oncology Centre
Start Date
2007-07
Trial ID
NCT00640081
It is a phase III trial to explore the efficacy and safety of utidelone plu...
Status
Not Yet Recruiting
Location
Shusen Wang
Start Date
2022-03-01
Trial ID
NCT05172518
The purpose of this study is to see if capecitabine can be taken safely wit...
Status
Completed
Location
University of Michigan Health System
Start Date
2016-01-06
Trial ID
NCT02650752
Treatments Being Tested
This 2 arm study will assess the efficacy and safety of intermittent oral X...
Status
Completed
Location
Multiple Locations
Start Date
2003-07
Trial ID
NCT00069108
Treatments Being Tested
This is a Phase II study of the drug combination of Oxaliplatin, Avastin an...
Status
Completed
Location
University of Pittsburgh Medical Center
Start Date
2005-01
Trial ID
NCT00177307
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Unknown
Location
Mercy University Hospital
Start Date
2005-03
Trial ID
NCT00182715
Treatments Being Tested
This is a randomized phase II study comprising of two treatment arms in pat...
Status
Completed
Location
Department of Clinical Oncology, Prince of Wales Hospital
Start Date
2007-09
Trial ID
NCT01243047
Treatments Being Tested
This study aimed to investigate the value of a novel strategy of intermitte...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-05-01
Trial ID
NCT06331845
Treatments Being Tested
To evaluate the response rate of capecitabine and irinotecan combination th...
Status
Completed
Location
National Cancer Center
Start Date
2006-08
Trial ID
NCT00532714
Treatments Being Tested